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TECHNICAL NOTE
Prevention of air travel–related deep venous
thrombosis with mechanical devices: Active foot
movements produce similar hemodynamic effects
Fedor Lurie, MD, PhD, Robert L. Kistner, MD, Bo Eklof, MD, PhD, and Jessica K. Tsukamoto, BS,
Honolulu, Hawaii
Objective: We compared the hemodynamic effects of different mechanical devices aimed for prevention of travel-related
deep venous thrombosis with active foot movements.
Methods: Two battery-operated intermittent pneumatic compression (IPC) devices and three foot and calf muscle pump
facilitating devices (PFD) that claimed to prevent travel-related deep venous thrombosis were tested in 17 healthy
volunteers on the ground and in 8 of same volunteers during flight. Flow changes during active foot movements were
compared with the effects of each of the tested devices.
Results: There was no significant difference in hemodynamic effect between PFDs and active foot movements. The
hemodynamic effects of IPC devices were significantly less compared with active foot movements. Values obtained during
air flights were not significantly different from those obtained on the ground.
Conclusions:Whereas IPC use for prevention of venous stasis during flight can be justified for immobile patients or during
sleep, PFDs do not provide additional hemodynamic benefits compared with simple movements of the foot. ( J Vasc Surg
2006;44:889-91.)The existence and magnitude of association between
prolonged air travel and venous thromboembolism have
been studied and debated for the last three decades.1,2
Prevention of venous thromboembolism events in air trav-
elers is an even more complicated issue that requires an
understanding of hemodynamic, hematologic, and envi-
ronmental mechanisms of thrombogenesis during flight.
Use of elastic compression and low-molecular-weight hep-
arin has been shown to be effective in the prevention of
subclinical deep venous thrombosis (DVT),3,4 and inter-
mittent pneumatic compression (IPC) has been suggested
as a preventive measure.5
Several recent episodes of fatal pulmonary embolism after
long air travel were widely publicized by the media.6-8 Public
attention to this issue has created educational opportunities,
but it has also provided a fertile commercial environment for
products aimed at DVT prevention. One class of such prod-
ucts, known as foot exercisers or calf muscle pump facilitating
devices (PFD), has been extensively advertised via the Internet
(eg, http://www.lymgym.com, http://www.preventproducts.
com, http://www.arjan.com, http://www.dvthealth.co.uk,
and http://www.airogym.com). The usual claims made
are that these devices facilitate calf muscle pump function
and prevent DVT by increasing the venous flow. Although
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The purpose of this study was to investigate the hemo-
dynamic effects of two groups of mechanical devices aimed
at prevention of travel-related DVT: IPC and PFD.
Changes in venous flow produced by active foot move-
ments were chosen as a reference point to answer the
question of whether any of the studied devices produces an
increase in venous flow superior to that caused by foot
movements. We attempted to study these effects during air
flights and on the ground.
METHODS
The study protocol was approved by the Institutional
Review Board of Hawaii Pacific Health, and written in-
formed consent was obtained from all participants. Seven-
teen healthy volunteers were recruited to participate in this
study. The average age was 43.6 years (range, 19-65 years);
there were eight women and nine men. Participants had no
history of heart disease, peripheral arterial disease, diabetes,
musculoskeletal disorders, or lymphedema. None of the
participants had a history of acute or chronic venous dis-
ease, unilateral leg edema, or previous vascular operations.
Each of the volunteers underwent a detailed venous duplex
ultrasound scan and ankle-brachial index measurement be-
fore inclusion in the study to confirm the absence of vascu-
lar abnormalities.
Each volunteer was examined in our vascular labora-
tory. In addition, 8 of the 17 volunteers were examined
during air flights from Hawaii to the mainland United
States from June to October 2002. In-flight testing was
performed within 48 hours from examination in the vascu-
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tions made it unfeasible to complete in-flight testing on the
remaining nine volunteers.
A portable ultrasound scanner (Sonosite 180 Plus with an
L38/10-5 MHz 38-mm linear array transducer; SonoSite,
Inc, Bothell, Wash) was used for all scans. Duplex scans
were performed with subjects sitting in a chair; all measure-
ments were performed at the proximal segment of the
popliteal vein of one randomly selected extremity. When
subjects were tested on the ground, their position was
modeled after the seat configuration of economy class seats.
Although the office chair was used, its width was 46 cm
(United Airlines seats are 45.7 cm; Delta airlines seats are
46 cm), the distance between the chair and the wall was set
at 80 cm (United Airlines’ pitch is 78.7 cm; Delta airlines’
pitch is 81 cm), and the back of the chair was angled at 20°,
which is similar to most airlines’ seat configurations.
The mean peak velocity (MPV), velocity time integral
(VTI), and diameter of the vein were measured. The MPV
increase was calculated as the difference between MPV
when a device was used and MPV at baseline divided by
MPV at baseline. The volume flow increase was calculated
as a ratio of VTI when a device was used and VTI at
baseline. It has been shown previously that changes in vein
diameter closely correlate with changes in flow velocity9;
therefore, when used for the same vein in the same individ-
ual, VTI ratios are equal to volume flow ratios.
Before the test, volunteers were instructed in and had
practiced performing foot movements and using PFDs
uniformly. After baseline measurements, participants were
asked to perform three foot movements (dorsal flexion
followed by plantar flexion) with 1-minute intervals be-
tween movements. After flow velocities returned to the
baseline level, other devices were tested in random order.
Flow velocities were recorded during three cycles for each
of the tested devices with one cycle per second. Velocities
were allowed to return to the baseline level before the next
device was tested. A contralateral extremity was used as a
control to identify whether any changes in venous flow
occurred during the test. All measurements and calcula-
tions were performed on recorded images by a technologist
blinded to which image corresponded to which device,
except for baseline measurements.
Devices
Three foot and calf muscle PFDs that claimed to prevent
travel-related DVT were selected: Ankle Pumper Assist (Pre-
vent Products, Inc, Mendota Heights, Minn), LymGym
(Lymgym Ltd, Woodbridge, UK), and U-SIT (Fordena Pty,
Ltd, Chatswood, NSW, Australia). The selected devices rep-
resent three groups of foot exercisers. Ankle Pumper Assist
provides foot support for dorsal and plantar flexions,
LymGym combines this support with passive movement of
the contralateral foot, and U-SIT applies pressure against
plantar venous plexus while the patient performs dorsal
flexion (Fig 1).
Two battery-powered IPC devices were tested: WizAir
(Medical Compression Systems Inc, Ltd, Or-Akiva, Israel)and Travel Air 8-Prototipe (ACI Medical, Inc, San Marcos,
Calif). The size, weight, and battery life of these devices
made them suitable for use during air flights. Only calf
sleeve garments were used for this study. Both devices had
similar compression profiles. Pressure in the garment was
controlled against the air pressure around the unit, so
changes in the air pressure in the cabin during flight did not
affect the relative pressure inside the garment.
Statistical analysis
Sample size calculation was based on our previous
studies of the hemodynamic effects of IPC devices and foot
movements.10 To determine a 10% difference between
devices with a power of 80% and a significance level of 5%,
15 participants were needed (SmplePower 2.0 statistical
software; SPSS Inc, Chicago, Ill). Because in-flight testing
was completed in only eight volunteers, the observed
power was calculated and reported when the results of
in-flight testing were not significantly different from those
of on-ground tests. Descriptive statistics are reported as
Table I. Mean peak velocities (MPVs) at baseline, during
foot movements, and during use of the tested devices on
the ground (n  17)
Variable*
MPV
P (paired t test)
Mean SD
Vs
baseline
Vs foot
movements
Baseline 6.23 1.92 NS .0001
Foot movements 28.48 3.87 .0001 NS
IPC1 20.75 0.94 .0001 .0001
IPC2 21.04 1.19 .0001 .0001
PFD1 28.56 3.79 .0001 .82
PFD2 28.62 3.48 .0001 .63
PFD3 28.56 4.39 .0001 .9
IPC, Intermittent pneumatic compression; PFD, pump facilitating device.
*IPC1, Wiz Air; IPC2, Travel Air 8-Prototipe; PFD1, Lym Gym; PFD2,
Ankle Pumper Assist; PDF3, U-SIT.
Table II. Mean peak velocities (MPVs) and volume flow
(VF) increase from the baseline values during foot
movements and during use of the tested devices on the
ground (n  17)
Variable*
MPV increase VF increase
Mean SD
P
compared
with foot
movements Mean SD
P
compared
with foot
movements
Foot
movement 3.87 1.05 NS 3.67 0.94 NS
IPC1 2.65 1.18 .032 2.59 1.18 .007
IPC2 2.7 1.18 .048 2.62 1.18 .01
PFD1 3.88 1.11 NS 3.71 0.98 NS
PFD2 3.9 1.04 NS 3.92 0.98 .97
PFD3 3.9 1.2 NS 3.91 1.18 .97
*IPC1, Wiz Air; IPC2, Travel Air 8-Prototipe; PDF1, Lym Gym; PDF2,
Ankle Pumper Assist; PDF3, U-SIT.means and standard deviations. Repeated-measures analysis
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model when appropriate. Bonferroni adjustment for mul-
tiple comparisons was used for comparison between multi-
ple devices. The level of statistical significance was set at
P  .05. SPSS 14.0 statistical software was used for all
calculations (SPSS Inc).
RESULTS
When tested on the ground, active foot movements
produced an MPV increase from 6.2 1.9 cm/s (at rest) to
28.5  3.9 cm/s. When PFDs were used, MPVs were
almost identical to those with foot movements (P  .5;
observed power,0.8). IPC devices produced lesser MPVs
than foot movements (Table I). The increase of venous
velocities and volume flow relating to the baseline values
followed same pattern (Table II). The hemodynamic effect
was not significantly different between the two tested IPC
devices or among the three PFDs. Values obtained during
air flights were not significantly different from those ob-
tained on the ground (P  .05; observed power, 0.77)
(Table III).
DISCUSSION
Venous stasis is considered one of the major contribu-
tors to the development of deep venous thrombi.11 Be-
Fig 1. Muscle pump facilitating devices.
Table III. Mean peak velocities (MPVs) at baseline,
during foot movements, and during use of the tested
devices on the ground and during flight (n  8)
Variable*
MPV on the
ground
MPV during
flight
P
valueMean SD Mean SD
Baseline 6.23 1.92 5.69 1.66 .15
Foot
movements 28.48 3.87 24.5 5.93 .19
IPC1 20.75 0.94 18.93 3.84 .24
IPC2 21.04 1.19 18.9 4.13 .24
PFD1 28.56 3.79 24.9 6.36 .17
PFD2 28.62 3.48 24.45 6.46 .15
PFD3 28.56 4.39 24.14 6.26 .19
*IPC1, Wiz Air; IPC2, Travel Air 8-Prototipe; PDF1, Lym Gym; PDF2,
Ankle Pumper Assist; PDF3, U-SIT.cause prolonged air travel significantly limits travelers’mobility, measures preventing venous stasis are highly de-
sirable, especially for individuals with an underlying pro-
thrombotic tendency. Although moderate exercise, such as
walking around the cabin, may solve this problem for awake
and mobile travelers, the limited space of the aircraft restricts
such activities, particularly for patients after orthopedic surger-
ies or those with obesity, who have high risk of DVT.
This study was focused on two groups of mechanical
devices that aimed to increase venous outflow from the lower
extremities. IPC devices have been widely used for DVT
prevention in immobile patients in hospital and nursing home
settings. IPC devices selected for this study have features that
make it possible to use them during air flight: they are light,
small, and battery powered. They do not require active move-
ments and therefore can be used in immobile patients or while
passengers are asleep. PFDs do require active foot movements
and therefore can be used only in active, awake individuals.
This study did not include patients with circulatory problems,
in whom tested devices may act differently.
Our findings confirmed that in healthy individuals, all of
the tested devices significantly increased venous blood flow
velocities and venous volume flow. However, the hemody-
namic effect of PFDs was not different from simple move-
ments of the foot, and tested IPC devices produced a lesser
hemodynamic effect than foot movements. Our observations
during air flights suggest that cabin environment does not
influence the hemodynamic effect of tested devices. Although
IPC use for prevention of venous stasis during flight can be
justified for immobile patients or during sleep, PFDs do not
provide additional hemodynamic benefits compared with sim-
ple movements of the foot.
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